SARS-CoV-2 and Hemodialysis: diffusion and mortality in patients and health care team. Reflections from the Lombardy experience

Rombolà, Giuseppe; Heidempergher, Marco; Cornacchiari, Marina; Baragetti, Ivano; Pieruzzi, Federico

doi:10.1007/s40620-021-01003-3

Cited by 3 publications

(2 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…La mortalidad en pacientes en HD afectados por SARS-CoV-2 es muy superior a la de la población general, y se encuentra en torno al 30 % en las series europeas, superior a la publicada en China al inicio de la pandemia (11)(12)(13).…”

Section: Discussionunclassified

Vascular access management during the COVID-19 pandemic period

Grossi¹,

Sauco²,

Strub³

et al. 2021

Angiologia

View full text Add to dashboard Cite

show abstract

Section: Discussionunclassified

Vascular access management during the COVID-19 pandemic period

Grossi¹,

Sauco²,

Strub³

et al. 2021

Angiologia

View full text Add to dashboard Cite

show abstract

“…In a study of a European kidney replacement therapy population, Jager et al reported that the attributable mortality rate for COVID-19 was 20.0% in 3285 patients on dialysis after a 28-day follow-up [ 16 ]. In a survey of nasopharyngeal swab tests for COVID-19 obtained from 1722 patients treated with hemodialysis in a region of northern Italy, Rombolà et al reported that 553 (32.1%) tested positive and the death was 171, representing a case fatality rate of 30.9% and mortality was 3.2%, which was much higher than the corresponding rates in the general population [ 17 ]. The main clinical symptoms in patients on hemodialysis with COVID-19 are fever, cough, fatigue and dyspnea, while some patients are asymptomatic [ 18 , 19 ].…”

Section: Clinical Characteristics and Prognosis Of Patients On Hemodi...mentioning

confidence: 99%

The prevention and treatment of COVID-19 in patients treated with hemodialysis

Zeng,

Zhou,

Peng

et al. 2023

Eur J Med Res

View full text Add to dashboard Cite

Patients treated with hemodialysis are often immunocompromised due to concomitant disease. As a result, this population is at high risk of infection and mortality from COVID-19. In addition to symptomatic treatment, a series of antiviral drugs targeting COVID-19 are now emerging. However, these antivirals are used mainly in mild or moderate patients with high-risk factors for progression to severe disease and are not available as pre- or post-exposure prophylaxis for COVID-19. There is a lack of clinical data on the use of anti-COVID-19 drugs, especially in patients treated with hemodialysis, therefore, vaccination remains the main measure to prevent SARS-CoV-2 infection in these patients. Here, we review the clinical features and prognosis of patients on hemodialysis infected with SARS-CoV-2, the main anti-COVID-19 drugs currently available for clinical use, and the safety and efficacy of anti-COVID-19 drugs or COVID-19 vaccination in patients treated with hemodialysis. This information will provide a reference for the treatment and vaccination of COVID-19 in patients treated with hemodialysis and maximize the health benefits of these patients during the outbreak.

show abstract

Involvement of healthcare staff in hospital hygiene during emergency hemodialysis

El Mahdi,

Imane,

Adil

et al. 2024

Hemodialysis International

View full text Add to dashboard Cite

BackgroundHealthcare‐associated infections are still a worrying health problem that complicates patient care and increases morbidity and mortality. The incidence of infections in hemodialysis patients is still high and they constitute the second cause of hospitalization and death in this category.AimsThe study's objective was to evaluate nursing and medical staff's involvement in hospital hygiene.MethodsThis is an observational study that took place within the hemodialysis unit of a Moroccan university hospital from March 2021 to June 2021. A surface swabbing technique for bacteriological examination was also carried out.ResultsThe study revealed some shortcomings regarding hand hygiene which was respected by the nurses in only 17.5% of sessions and in 42.2% by the doctors. Other shortcomings in asepsis measures, were also noted such as the non‐change of gloves after skin preparation (1.03%) and before manual compression. The serological status of patients concerning HBV, HVC, and HIV was also not always known (31.1%). The bacteriological samples from the surfaces also showed colonization of the medical devices and the ultrasound scanner used for the ultrasound‐guided introduction of the central catheters. The results of the study showed some deviations concerning the recommendations; however, they are comparable to other studies conducted internationally, especially in terms of hand hygiene.ConclusionOur study results highlight some shortcomings adherence to hygiene measures like inconsistent disinfection of medical devices and dialysis stations, as well as insufficient hand hygiene practices among some staff members. However, we observed an improvement in practices following the implementation of awareness‐raising sessions. To maintain improved hygiene practices and prevent infections, it is crucial to provide ongoing training for staff, ensure adequate resources, and regularly monitor compliance with hygiene standards.

show abstract

SARS-CoV-2 and Hemodialysis: diffusion and mortality in patients and health care team. Reflections from the Lombardy experience

Cited by 3 publications

References 4 publications

Vascular access management during the COVID-19 pandemic period

Vascular access management during the COVID-19 pandemic period

The prevention and treatment of COVID-19 in patients treated with hemodialysis

Involvement of healthcare staff in hospital hygiene during emergency hemodialysis

Contact Info

Product

Resources

About